GreatPoint Ventures leads Series B round for Truvian Sciences

Truvian Sciences, a provider of routine health testing services, has secured $27.1 million in Series B financing. GreatPoint Ventures led the round with participation from other investors that included DNS Capital, Tao Capital Partners and Domain Associates.